Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 22
Filtrar
1.
Clin Exp Dermatol ; 49(6): 591-598, 2024 May 21.
Artigo em Inglês | MEDLINE | ID: mdl-38214576

RESUMO

BACKGROUND: Dermoscopy is known to increase the diagnostic accuracy of pigmented skin lesions (PSLs) when used by trained professionals. The effect of dermoscopy training on the diagnostic ability of dermal therapists (DTs) has not been studied so far. OBJECTIVES: This study aimed to investigate whether DTs, in comparison with general practitioners (GPs), benefited from a training programme including dermoscopy, in both their ability to differentiate between different forms of PSL and to assign the correct therapeutic strategy. METHODS: In total, 24 DTs and 96 GPs attended a training programme on PSLs. Diagnostic skills as well as therapeutic strategy were assessed, prior to the training (pretest) and after the training (post-test) using clinical images alone, as well as after the addition of dermatoscopic images (integrated post-test). Bayesian hypothesis testing was used to determine statistical significance of differences between pretest, post-test and integrated post-test scores. RESULTS: Both the DTs and the GPs demonstrated benefit from the training: at the integrated post-test, the median proportion of correctly diagnosed PSLs was 73% (range 30-90) for GPs and 63% (range 27-80) for DTs. A statistically significant difference between pretest results and integrated test results was seen, with a Bayes factor > 100. At 12 percentage points higher, the GPs outperformed DTs in the accuracy of detecting PSLs. CONCLUSIONS: The study shows that a training programme focusing on PSLs while including dermoscopy positively impacts detection of PSLs by DTs and GPs. This training programme could form an integral part of the training of DTs in screening procedures, although additional research is needed.


Assuntos
Competência Clínica , Dermoscopia , Clínicos Gerais , Dermoscopia/educação , Dermoscopia/métodos , Humanos , Clínicos Gerais/educação , Neoplasias Cutâneas/diagnóstico , Neoplasias Cutâneas/diagnóstico por imagem , Feminino , Masculino , Dermatologistas/educação , Dermatologistas/estatística & dados numéricos , Educação Médica Continuada/métodos , Adulto
4.
PLoS One ; 17(1): e0260978, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-35073333

RESUMO

BACKGROUND: The incidence of keratinocyte carcinomas is high and rapidly growing. Approximately 80% of keratinocyte carcinomas consist of basal cell carcinomas (BCC) with 50% of these being considered as low-risk tumors. Nevertheless, 83% of the low-risk BCC patients were found to receive more follow-up care than recommended according to the Dutch BCC guideline, which is one visit post-treatment for this group. More efficient management could reduce unnecessary follow-up care and related costs. OBJECTIVES: To study the efficacy, cost-utility, and budget impact of a personalized discharge letter for low-risk BCC patients compared with usual care (no personalized letter). METHODS: In a multi-center intervention study, a personalized discharge letter in addition to usual care was compared to usual care in first-time BCC patients. Model-based cost-utility and budget impact analyses were conducted, using individual patient data gathered via surveys. The outcome measures were number of follow-up visits, costs and quality adjusted life years (QALY) per patient. RESULTS: A total of 473 first-time BCC patients were recruited. The personalized discharge letter decreased the number of follow-up visits by 14.8% in the first year. The incremental costs after five years were -€24.45 per patient. The QALYs were 4.12 after five years and very similar in both groups. The national budget impact was -€2,7 million after five years. CONCLUSIONS: The distribution of a personalized discharge letter decreases the number of unnecessary follow-up visits and implementing the intervention in a large eligible population would results in substantial cost savings, contributing to restraining the growing BCC costs.


Assuntos
Assistência ao Convalescente/economia , Carcinoma Basocelular/terapia , Neoplasias Cutâneas/terapia , Adulto , Idoso , Idoso de 80 Anos ou mais , Carcinoma Basocelular/economia , Análise Custo-Benefício , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Modelos Econômicos , Países Baixos , Sumários de Alta do Paciente Hospitalar , Guias de Prática Clínica como Assunto , Medicina de Precisão , Anos de Vida Ajustados por Qualidade de Vida , Neoplasias Cutâneas/economia , Padrão de Cuidado , Avaliação da Tecnologia Biomédica
7.
Melanoma Res ; 30(5): 511-514, 2020 10.
Artigo em Inglês | MEDLINE | ID: mdl-32732695

RESUMO

Variants in the Melanocortin 1 Receptor (MC1R) gene have been associated with an increased risk of melanoma, but the role in nevus count is unclear. We investigated if specific MC1R gene variants or the number of MC1R gene variants and phenotypical features were associated with nevus count. A total of 494 participants of the 'Leiden skin cancer study' were included and the MC1R gene coding sequence was analysed by single-strand conformation polymorphism analysis followed by sequencing of unknown variants. The association between MC1R gene variants and nevus count and the association between age, gender and phenotypical features and nevus count were studied using the Chi-square test. Study of nine frequently occurring MC1R gene variants in participants without skin cancer (n = 203) showed that the 'r' Val60Leu variant was significantly associated with high nevus count (>50 nevi) (P = 0.017). This association was very strong among women (P < 0.001), but not present among men. Having one or two MC1R variants in general did not show a significant difference in the nevus count. Hair colour, skin type, eye colour and age were not significantly associated with nevus count, whereas gender showed a significant association (P = 0.008), with the highest nevus counts in female. The Val60Leu variant of the MC1R gene could be a promising candidate as an independent predictor of high nevus count, particularly in women. This information about the genetic makeup could promote personalized follow-up strategies and might help to prevent skin cancer in the future.


Assuntos
Melanoma/genética , Nevo/genética , Receptor Tipo 1 de Melanocortina/genética , Neoplasias Cutâneas/genética , Adulto , Feminino , Humanos , Masculino , Melanoma/patologia , Pessoa de Meia-Idade , Fenótipo , Neoplasias Cutâneas/patologia
8.
Acta Oncol ; 59(1): 4-12, 2020 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-31347929

RESUMO

Background: Older people have the highest incidence of melanoma and the population in most Western countries is ageing. We evaluated how the gap in incidence and survival between younger and older patients has developed during the past decades.Material and methods: All patients diagnosed with cutaneous melanoma between 1989 and 2015 (n = 84,827) were identified from the Netherlands Cancer Registry. Elderly were defined as aged ≥70 years. Differences in patient and tumor characteristics were described, age-specific incidence rates were calculated, and relative survival (RS) and multivariable analyses estimating the Relative Excess Rate of dying (RER) were conductedResults: In older men, the melanoma age-standardized incidence increased from 18 to 103/100,000 person-years (py) between 1989 and 2015 and in older women from 23 to 70/100,000 py. In younger men and women, it increased from 8 to 21 and from 13 to 28/100,000 py, respectively. Median Breslow thickness declined from 1.8 to 1.1 mm and from 1.6 to 1.1 mm in older men and women (2003 versus 2015), and from 1.1 to 0.9 mm and 0.9 to 0.8 mm in younger men and women. In older men, 5-year RS increased from 67% (95% CI: 63%-72%) in 1989-1997 to 85% (95% CI: 83%-87%) in 2007-2015 and in older women from 81% (95% CI: 78%-85%) to 89% (95% CI: 87%-91%). In younger men and women, RS increased from 82% (95% CI: 81%-83%) to 90% (95% CI: 90%-91%) and from 92% (95% CI: 92%-93%) to 96% (95% CI: 95%-96%). After case-mix correction , older men and women no longer showed an improved survival over time (RER 2010-2015 versus 2003-2009: 0.97; 95% CI: 0.81-1.16 and 0.95; 95% CI: 0.79-1.16). Whereas in younger men and women survival remained improved (RER 0.75; 95% CI: 0.67-0.83 and 0.77; 95%CI: 0.67-0.89).Conclusion: The gap in melanoma incidence between younger and older people is increasing due to a strong increase in incidence in older adults. Disparities in survival are declining, related to a narrowing gap in Breslow thickness.


Assuntos
Melanoma/mortalidade , Neoplasias Cutâneas/mortalidade , Fatores Etários , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Incidência , Masculino , Melanoma/epidemiologia , Melanoma/patologia , Pessoa de Meia-Idade , Gradação de Tumores , Estadiamento de Neoplasias , Países Baixos/epidemiologia , Sistema de Registros/estatística & dados numéricos , Fatores de Risco , Fatores Sexuais , Neoplasias Cutâneas/epidemiologia , Taxa de Sobrevida
9.
Acta Derm Venereol ; 98(7): 667-670, 2018 Jul 11.
Artigo em Inglês | MEDLINE | ID: mdl-29542807

RESUMO

Approximately 10% of all melanomas occur in subjects with a family history of melanoma. This retrospective follow-up study investigated the characteristics of patients with familial melanoma who made unscheduled visits to our pigmented lesions clinic, and the diagnosis of excised lesions. A total of 110 (9%) out of 1,267 patients made at least one unscheduled visit between May 2011 and February 2016. Histopathology was taken from 59 patients. Thirty-four naevi, 7 melanomas and 3 basal cell carcinomas were detected. All patients with melanoma were CDKN2A carriers and all melanomas were discovered at a very early stage. In this patient population it appears to be safe to limit visits to once or twice yearly, provided patients are easily able to make an unscheduled extra visit if they have a worrisome lesion. We recommend supporting patients' self-reliance by stimulating them to carry out self-examination of their skin.


Assuntos
Agendamento de Consultas , Carcinoma Basocelular/patologia , Melanoma/patologia , Nevo/patologia , Visita a Consultório Médico , Neoplasias Cutâneas/patologia , Adolescente , Adulto , Idoso , Biomarcadores Tumorais/genética , Carcinoma Basocelular/genética , Carcinoma Basocelular/cirurgia , Criança , Inibidor p16 de Quinase Dependente de Ciclina , Inibidor de Quinase Dependente de Ciclina p18/genética , Feminino , Seguimentos , Predisposição Genética para Doença , Acessibilidade aos Serviços de Saúde , Hereditariedade , Humanos , Masculino , Melanoma/genética , Melanoma/cirurgia , Pessoa de Meia-Idade , Mutação , Estadiamento de Neoplasias , Nevo/genética , Nevo/cirurgia , Fenótipo , Estudos Retrospectivos , Autoexame , Neoplasias Cutâneas/genética , Neoplasias Cutâneas/cirurgia , Adulto Jovem
12.
Acta Derm Venereol ; 96(2): 186-90, 2016 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-26315708

RESUMO

Skin self-examination can help patients who are at high risk for developing melanoma to become more involved in their own surveillance and treatment. This study examined the use of total body photography as an aid to skin self-examination from the patients' perspective. A total of 179 individuals at high risk for developing melanoma who had undergone total body photography (60.5% response rate) completed a self-reported questionnaire assessing the frequency of skin self-examination, perceived usefulness of total body photography, and a variety of potential demographic, clinical and psychological factors. Only approximately half of the participants indicated skin self-examination as useful and 78.9% preferred clinical skin examination by a specialist. Finding total body photography useful was associated with having received instructions on how to perform skin self-examination, the use of a (hand)mirror, and confidence to detect changing moles. These findings allow us to develop strategies to further improve patients' self-screening behaviours.


Assuntos
Conhecimentos, Atitudes e Prática em Saúde , Melanoma/diagnóstico , Pacientes/psicologia , Percepção , Fotografação , Autoexame/métodos , Neoplasias Cutâneas/diagnóstico , Adulto , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Preferência do Paciente , Valor Preditivo dos Testes , Fatores de Risco , Inquéritos e Questionários
13.
Ned Tijdschr Geneeskd ; 159: A9425, 2015.
Artigo em Holandês | MEDLINE | ID: mdl-26629603

RESUMO

Childhood melanoma is a rare disorder which is often associated with a diagnostic delay. Worldwide, the incidence of cutaneous melanoma is rising in both adults and children. We describe three cases of childhood melanoma in the Netherlands which illustrate different aetiological aspects of the disease. The epidemiology of childhood melanoma in the Netherlands is discussed. In reviewing the literature, we wish to draw attention to important clinical aspects which may contribute to the early recognition of melanoma in children.


Assuntos
Melanoma/epidemiologia , Neoplasias Cutâneas/epidemiologia , Adolescente , Criança , Diagnóstico Tardio , Feminino , Humanos , Incidência , Masculino , Melanoma/diagnóstico , Países Baixos/epidemiologia , Neoplasias Cutâneas/diagnóstico , Melanoma Maligno Cutâneo
14.
Ned Tijdschr Geneeskd ; 158: A8113, 2014.
Artigo em Holandês | MEDLINE | ID: mdl-25370949

RESUMO

The definitive results of the MSLT-1 study in melanoma patients were published recently. The sentinel lymph node (SLN) procedure shows no survival benefit compared with observation. The authors reported, however, that there was a survival benefit with "biopsy management" of patients. This statement is based on subgroup analyses that we find to be incorrect for three reasons: (a) patients with a false negative SLN were incorrectly left out of consideration; (b) accelerated failure time latent subgroup analysis is an unproven statistical hypothesis, which was developed on interim data from the MSLT-1 study, and therefore cannot be used as validation; (c) there is a significant difference in terms of the percentage of patients with affected lymph nodes between the SLN group and the observation group. This excess of "prognostic false positive" patients would have incorrectly falsely improved the survival of the SLN group. We concluded that the SLN procedure does not give a survival benefit and that its role in melanoma patients should be for staging purposes and not for therapeutic purposes.


Assuntos
Melanoma/patologia , Estadiamento de Neoplasias , Biópsia de Linfonodo Sentinela , Neoplasias Cutâneas/patologia , Humanos , Excisão de Linfonodo/métodos , Metástase Linfática/patologia , Prognóstico
15.
Cancer Epidemiol Biomarkers Prev ; 22(10): 1771-7, 2013 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-23897584

RESUMO

BACKGROUND: Lifetime melanoma risk of mutation carriers from families with a germline mutation in the CDKN2A gene is estimated to be 67%. The necessity to include family members in a melanoma surveillance program is widely endorsed, but there is no consensus on which family members should be invited. METHODS: In a retrospective follow-up study, we investigated the yield of surveillance of first- and second-degree relatives of melanoma and pancreatic cancer patients from 21 families with the "p16-Leiden" CDKN2A mutation. Melanoma incidence rates were compared with the general population. RESULTS: Three-hundred and fifty-four first-degree relatives and 391 second-degree relatives were included. Forty-five first-degree relatives and 11 second-degree relatives were diagnosed with melanoma. Most (72%) of second-degree relatives diagnosed with melanoma had become a first-degree relative before diagnosis, due to the occurrence of a melanoma in a parent or sibling. Overall, melanoma incidence rate was 2.1 per 1,000 person years [95% confidence interval (CI), 1.2-3.8] in family members still being second-degree relatives at diagnosis, compared with 9.9 per 1,000 person years (95% CI, 7.4-13.3) in first-degree relatives. The standardized morbidity ratio for melanoma of second-degree relatives compared with the general population was 12.9 (95% CI, 7.2-23.4). CONCLUSION: Second-degree relatives from families with the p16-Leiden mutation in CDKN2A have a considerably increased melanoma risk compared with the general population. IMPACT: This study provides justification for the surveillance of second-degree relatives from families with a CDKN2A germline mutation.


Assuntos
Genes p16 , Mutação em Linhagem Germinativa , Melanoma/genética , Neoplasias Cutâneas/genética , Adolescente , Adulto , Idoso , Criança , Saúde da Família , Feminino , Predisposição Genética para Doença , Humanos , Incidência , Masculino , Melanoma/epidemiologia , Pessoa de Meia-Idade , Neoplasias Pancreáticas/epidemiologia , Neoplasias Pancreáticas/genética , Estudos Retrospectivos , Neoplasias Cutâneas/epidemiologia , Adulto Jovem , Melanoma Maligno Cutâneo
16.
Acta Derm Venereol ; 92(6): 587-92, 2012 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-22965007

RESUMO

Individuals with two red hair colour (RHC)-MC1R genetic variants have light skin and blond/reddish hair and, in comparison with those without such alleles, are at an increased risk of developing melanoma. Our study investigated the association of RHC variants and the Total Dermo-scopy Score (TDS), and the items that make up the TDS, in those with atypical naevi and melanomas from high risk melanoma patients. Eight hundred and seventy-six atypical naevi and 21 melanomas were scored according to the TDS system and MC1R polymorphisms were determined. Analyses revealed that several TDS items including pigment network, dark-brown colour and streaks were more frequently observed in atypical naevi from individuals without RHC variants, while structureless areas were more often observed in individuals with two RHC variants. Finally, no significant difference in TDS was detected in atypical naevi from individuals with two RHC variants compared to those without RHC. Clinicians should be aware of a different dermoscopic naevus pheno-type in patients with light blond or RHC MC1R variants.


Assuntos
Dermoscopia , Melanoma/genética , Nevo Pigmentado/genética , Polimorfismo Genético , Receptor Tipo 1 de Melanocortina/genética , Neoplasias Cutâneas/genética , Pele/patologia , Distribuição de Qui-Quadrado , Inibidor p16 de Quinase Dependente de Ciclina/genética , Predisposição Genética para Doença , Cor de Cabelo/genética , Humanos , Modelos Lineares , Modelos Logísticos , Melanoma/patologia , Mutação , Nevo Pigmentado/patologia , Fenótipo , Valor Preditivo dos Testes , Fatores de Risco , Neoplasias Cutâneas/patologia , Pigmentação da Pele/genética
19.
Acta Derm Venereol ; 91(4): 428-31, 2011 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-21625824

RESUMO

Few studies have investigated the impact of dermoscopy on the management of relatives from melanoma families. The objective of this study was to assess the impact of dermoscopy on clinical diagnosis and management decisions in high-risk familial melanoma patients. In a prospective study 132 consecutive patients were recruited from the pigmented lesions clinic of a tertiary reference centre for familial melanoma. Dermatologists expert in dermoscopy identified 49 suspicious pigmented lesions and recorded pre- and post-dermoscopy diagnoses and management decisions. Dermoscopy was performed in 37% of the patients. Two melanomas were identified. Dermoscopy did not influence sensitivity (1.0), but resulted in 42% fewer excisions, increasing specificity from 0.53 to 0.74 (p = 0.031). Dermoscopy resulted in a large reduction in the number of unnecessary excisions. These results suggest that the main effect of dermoscopy in clinical practice for this high risk population is a significant increase in specificity, rather than sensitivity.


Assuntos
Dermoscopia , Síndrome do Nevo Displásico/diagnóstico , Melanoma/diagnóstico , Nevo Pigmentado/diagnóstico , Neoplasias Cutâneas/diagnóstico , Biópsia , Síndrome do Nevo Displásico/genética , Síndrome do Nevo Displásico/cirurgia , Genes p16 , Predisposição Genética para Doença , Humanos , Melanoma/genética , Melanoma/cirurgia , Mutação , Países Baixos , Nevo Pigmentado/genética , Nevo Pigmentado/cirurgia , Linhagem , Fenótipo , Valor Preditivo dos Testes , Prognóstico , Estudos Prospectivos , Neoplasias Cutâneas/genética , Neoplasias Cutâneas/cirurgia , Procedimentos Desnecessários
20.
J Am Acad Dermatol ; 65(2): 289-296, 2011 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-21570154

RESUMO

BACKGROUND: For more than 25 years families with an increased susceptibility to melanoma have been under surveillance at our institution. OBJECTIVE: We sought to investigate the effectiveness of surveillance for CDKN2A-mutated families and causes for failure of the program in patients with more advanced tumors. METHODS: In a retrospective case-control study, Breslow thickness of melanomas diagnosed in relatives enrolled in the surveillance program were compared with melanomas of unscreened index patients. We investigated the influence of mode of detection and length of surveillance interval on outcome. RESULTS: Surveillance melanomas (n = 226, median thickness: 0.50 mm) had a significantly lower Breslow thickness (multiplication factor: 0.61 [95% confidence interval 0.47-0.80], P < .001) than index melanomas (n = 40, median thickness: 0.98 mm). Index melanomas were more likely diagnosed with a Breslow thickness greater than 1.0 mm (odds ratio: 3.1 [95% confidence interval 1.2-8.1], P = .022). In all, 53% of surveillance melanomas were diagnosed during regular screens, 7% during patients' first screen, 20% between regular screens, and 20% in patients who were noncompliant with the surveillance schedule. The majority of surveillance melanomas (58%) were detected within 6 months after the last screen. There was no correlation between tumor thickness and the length of the screening interval for tumors diagnosed within 24 months since the last screen. LIMITATIONS: The study is retrospective. CONCLUSIONS: Surveillance was associated with earlier detection of melanomas. Noncompliance was an important cause for failing surveillance. Shortening surveillance intervals may advance detection of tumors, but may paradoxically have little impact on prognosis.


Assuntos
Genes p16 , Predisposição Genética para Doença/epidemiologia , Programas de Rastreamento/organização & administração , Melanoma/genética , Linhagem , Neoplasias Cutâneas/genética , Distribuição por Idade , Biópsia por Agulha , Estudos de Casos e Controles , Intervalos de Confiança , Detecção Precoce de Câncer , Feminino , Mutação em Linhagem Germinativa , Humanos , Imuno-Histoquímica , Incidência , Masculino , Melanoma/diagnóstico , Melanoma/epidemiologia , Estadiamento de Neoplasias , Razão de Chances , Prognóstico , Estudos Retrospectivos , Medição de Risco , Sensibilidade e Especificidade , Distribuição por Sexo , Neoplasias Cutâneas/diagnóstico , Neoplasias Cutâneas/epidemiologia , Análise de Sobrevida
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...